Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,609 signal articles · 224 in last 24h · 133,831 total before filter · latest 21m ago
224last 24h
1111last 7d
170● bullish (7d)
132● bearish (7d)
208publishers
AllMacro283Earnings385M&A71Regulatory28Product10Analyst17
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Innodata (INOD) Reaffirmed 2026 Growth, Is A 56% Undervalued View Justified?
Simply Wall St.8h agoneutral
Innodata (INOD) Reaffirmed 2026 Growth, Is A 56% Undervalued View Justified?

Innodata (INOD) recently reported a 58% year over year revenue surge and reaffirmed its 2026 revenue growth outlook of at least 40%, highlighting management’s confidence in the company’s AI focused data engineering model. Despite the strong revenue update, Innodata’s share price has been under pressure recently, with the stock down 14.18% over the past month and 55.32% over the past 90 days. This comes even as the 1 year total shareholder return sits at 48.01% and the 5 year total shareholder...

Ford Motor (F) Names New Energy Chief, Is The Stock Fully Valued?
Simply Wall St.8h agoneutral
Ford Motor (F) Names New Energy Chief, Is The Stock Fully Valued?

Ford Motor (F) has drawn fresh attention after naming Dave Carroll as president of Ford Energy following Lisa Drake’s retirement announcement. The leadership change gives investors new context for assessing the stock. Ford Motor’s share price has moved higher over the past week, with a 1-day share price return of 2.17% and a 7-day share price return of 1.73%. It is still down 7.82% over 90 days, while the 1-year total shareholder return of 27.36% points to momentum that has been building over...

Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. Patients
Simply Wall St.8h agoneutral
Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. Patients

Biogen (NasdaqGS: BIIB) and Eisai launched LEQEMBI IQLIK, a once-weekly subcutaneous injection for early Alzheimer's disease, now available in the U.S. for initiation and maintenance therapy. The treatment allows at-home dosing for eligible patients using a pre-filled syringe or autoinjector, following a step-up initiation schedule. LEQEMBI IQLIK is described as the first anti-amyloid therapy with an approved subcutaneous initiation option that can be started outside an infusion...

AeroVironment Lands Historic U.S. Laser Weapon Production Contract
Benzinga8h agoneutral
AeroVironment Lands Historic U.S. Laser Weapon Production Contract

AeroVironment, Inc. (NASDAQ:AVAV) shares are up almost 4% during Thursday’s premarket session as traders react to nearly 500 million in fresh U.S. Army contract news announced on Wednesday. The company won a $464.8 million contract from the U.S. Army Portfolio Acquisition Executive for Fires program office for the Enduring-High Energy Laser (E-HEL) program.Wins U.S. Army LOCUST Counter-UAS ContractThe award marks the first production contract for directed energy systems in U.S. history, moving l

Ross Gerber Points to SpaceX to Explain Why He Finds Bitcoin Price Predictions 'One of the Funnier Ideas'
Benzinga8h agoneutral
Ross Gerber Points to SpaceX to Explain Why He Finds Bitcoin Price Predictions 'One of the Funnier Ideas'

Well-known investor Ross Gerber highlighted fundamental differences in how public stocks like Space Exploration Technologies Corp. (NASDAQ:SPCX) are valued compared with Bitcoin (CRYPTO: BTC). ‘Well-Worn Methods’ Available to Value Public Stocks In an exclusive interview with Benzinga, Gerber said he finds Bitcoin price predictions “one of the funnier ideas,” questioning how anyone can set a target for an asset with no earnings or revenue. Gerber, co-founder of investment firm Gerber Kawasaki, s

Investing.com8h agoneutral
Tesla to unveil Cybercab Texas today, details are few

Investing.com -- Tesla Inc will present its two-seater Cybercab at an event in Texas today, providing a closer look at the autonomous vehicle that CEO Elon Musk has described as essential to making the company a leading player in driverless transportation.

What's Going On With Credo Technology Stock Thursday?
Benzinga8h agoneutral
What's Going On With Credo Technology Stock Thursday?

Credo Technology Group Holding Ltd. (NASDAQ:CRDO) stock edged lower in Thursday’s premarket trading after plunging 20.04% in the previous session, as investors weighed rapid growth against shrinking margins and rising costs.The stock’s modest gain suggested it was stabilizing after a post-earnings pullback. Credo reported fiscal 2027 first-quarter revenue of $479 million, beating the $471.77 million estimate. Adjusted earnings of $1.20 per share topped the $1.17 estimate.However, GAAP gross marg

3 of Wall Street’s Favorite Stocks We’re Skeptical Of
StockStory8h agoneutral
3 of Wall Street’s Favorite Stocks We’re Skeptical Of

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.